Novartis AG
Biomarkers predictive of therapeutic responsiveness to chimeric antigen receptor therapy and uses thereof
Last updated:
Abstract:
Cancer biomarkers and methods of using them are disclosed.
Status:
Grant
Type:
Utility
Filling date:
7 Oct 2015
Issue date:
15 Sep 2020